Concepedia

Dipen Patel

DP

17

Publications

558

Citations

13

H-Index

2009

Active since

Affiliations

Pharmerit (United States)(Current)

Pfizer (United States)

Virginia Commonwealth University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Health Economics and Outcomes Research (United Kingdom)

Dipen Patel is an author at Pharmerit (United States) specializing in medicine, food policy, and allergy.

ORCID

Top concepts

Publications per year

2009–2021

17

Publications

17

Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States

Dipen Patel, David A. Holdford, Eric S. Edwards et al. · Journal of Allergy and Clinical Immunology · 2011 · 182 citations · Full text

, , +10

Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact

Keith S. Kaye, Dipen Patel, Jennifer Stephens et al. · PLoS ONE · 2015 · 93 citations · Full text

Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

Viktor Chirikov, Ingrid Ma, Namita Joshi et al. · Value in Health · 2018 · 31 citations · Full text

Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective

Adnan Alsumali, Laurence Djatche, Andrew Briggs et al. · PharmacoEconomics · 2021 · 31 citations · Full text

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

Dipen Patel, Andrew F. Shorr, Jean Chastre et al. · Critical Care · 2014 · 24 citations · Full text

Rows per page

1–5 of 17